Literature DB >> 10338519

Levels of gamma interferon and interleukin-4 are inversely related to the levels of their corresponding autoantibodies in patients with lower respiratory tract infection.

R ElKarim1, C Granert, L Lindquist, H Link, M Bakhiet.   

Abstract

To study the involvement of cytokines and their corresponding autoantibodies (Aabs) in inflammatory mechanisms in patients with lower respiratory tract infections, blood samples were taken from patients at the time of admission to the hospital and before treatment. Cell-released capturing enzyme-linked immunosorbent assay was used to measure the levels of gamma interferon (IFN-gamma) and interleukin-4 (IL-4) produced spontaneously by peripheral mononuclear cells (PMNC). ELISA was used to measure Aabs to these cytokines in sera. The levels of both cytokines were inversely related to the levels of their corresponding Aabs. While a high level of IFN-gamma was observed together with a low level of anti-IFN-gamma Aab, decreased IL-4 levels were observed with increased levels of Aabs to IL-4. Immunoglobulins were purified, digested to obtain Fab fragments, and tested for specificity and cross-reactivity. The Aabs and their Fab fragments were tested in cytokine biological assays and showed neutralizing effects. Our data demonstrated increased levels of the proinflammatory cytokine IFN-gamma and decreased release of the anti-inflammatory cytokine IL-4 during early presentation of lower respiratory tract infection. The levels of these cytokines were inversely related to the levels of their corresponding Aabs that exhibited regulatory effects on the cytokine biological function in vitro.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10338519      PMCID: PMC96620          DOI: 10.1128/IAI.67.6.3051-3054.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  A new cell enzyme-linked immunosorbent assay demonstrates gamma interferon suppression by beta interferon in multiple sclerosis.

Authors:  M Bakhiet; V Ozenci; C Withagen; M Mustafa; S Fredrikson; H Link
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  IL-4 inhibits the synthesis of IFN-gamma and induces the synthesis of IgE in human mixed lymphocyte cultures.

Authors:  D Vercelli; H H Jabara; R P Lauener; R S Geha
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

3.  Contingent genetic regulatory events in T lymphocyte activation.

Authors:  G R Crabtree
Journal:  Science       Date:  1989-01-20       Impact factor: 47.728

4.  IgG autoantibodies against interleukin 1 alpha in sera of normal individuals.

Authors:  M Svenson; L K Poulsen; A Fomsgaard; K Bendtzen
Journal:  Scand J Immunol       Date:  1989-04       Impact factor: 3.487

5.  Preparation of Fab fragments from IgGs of different animal species.

Authors:  M G Mage
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  HIV antigen-induced release of histamine from basophils from HIV infected patients. Mechanism and relation to disease progression and immunodeficiency.

Authors:  M Pedersen; C M Nielsen; H Permin
Journal:  Allergy       Date:  1991-04       Impact factor: 13.146

7.  Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin 4 and interferon-gamma.

Authors:  I Chrétien; J Pène; F Brière; R De Waal Malefijt; F Rousset; J E De Vries
Journal:  Eur J Immunol       Date:  1990-02       Impact factor: 5.532

Review 8.  Autoantibodies to cytokines--friends or foes?

Authors:  K Bendtzen; M Svenson; V Jønsson; E Hippe
Journal:  Immunol Today       Date:  1990-05

Review 9.  Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-gamma.

Authors:  T Olsson
Journal:  J Neuroimmunol       Date:  1992-10       Impact factor: 3.478

10.  Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors.

Authors:  M A Collart; D Belin; J D Vassalli; S de Kossodo; P Vassalli
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.